Guo, J., Wu, T., Huang, T., Kuo, H., Chuang, C., Lu, W., Lin, C., Hsu, C. (2025). A phase II study of sacituzumab govitecan for advanced esophageal squamous cell carcinoma patients (SG-ESCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4208